Immunome Inc. (IMNM) stock
IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.18−0.43 (-2.44%)
Close on Nov 17, 2026Market cap $1.95BP/E –Yield –
Immunome price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Immunome's price to book ratio was 3.7× on Nov 11, 2026, against 6.4× a year earlier. Over the last 5 years it ranged from 0.9× to 33.3×, with a median of 3.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.7× | −3.8 |
| 2025 | Dec 31, 2025 | 7.5× | +4.5 |
| 2024 | Dec 31, 2024 | 3.0× | −18.5 |
| 2023 | Dec 29, 2023 | 21.5× | +20.3 |
| 2022 | Dec 30, 2022 | 1.2× | −1.7 |
| 2021 | Dec 31, 2021 | 2.9× | – |
See a number that looks wrong?